Cargando…

Do Genetic Polymorphisms Modulate Response Rate and Toxicity of Cisplatin Associated With Radiotherapy in Laryngeal Squamous Cell Carcinoma?: A Case Report

Cisplatin (CDDP) plus radiotherapy (RT) has been used to treat advanced laryngeal squamous cell carcinoma (LSCC) patients. Single nucleotide polymorphisms (SNPs) may be responsible for differences in chemo/radiosensitivity and side effects in those patients. We reported an advanced LSCC patient, who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopes-Aguiar, Leisa, Visacri, Marília Berlofa, Nourani, Carolina Marques Lopes, Costa, Ericka Francislaine Dias, Nogueira, Guilherme Augusto Silva, Lima, Tathiane Regine Penna, Pincinato, Eder Carvalho, Moriel, Patrícia, Altemani, João Maurício Carrasco, Lima, Carmen Silvia Passos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2015
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602693/ https://www.ncbi.nlm.nih.gov/pubmed/25906090 http://dx.doi.org/10.1097/MD.0000000000000578

Ejemplares similares

Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients
por: Nogueira, Guilherme Augusto Silva, et al.
Publicado: (2018)

XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
por: Lopes-Aguiar, Leisa, et al.
Publicado: (2016)

Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study
por: Visacri, Marília Berlofa, et al.
Publicado: (2017)

Leukocytoclastic vasculitis complicating cisplatin + radiation treatment for laryngeal cancer: a case report
por: Quintanilha, Júlia Coelho França, et al.
Publicado: (2017)

GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation
por: Pincinato, Eder C., et al.
Publicado: (2019)

Assessment of Renal Function in Head and Neck Cancer Patients Treated with Cisplatin: Different Biomarkers and Acute Kidney Injury Classifications
por: de Godoy Torso, Nadine, et al.
Publicado: (2022)

Cost-minimization analysis of GSTP1c.313A>G genotyping for the prevention of cisplatin-induced nausea and vomiting: A Bayesian inference approach
por: Macedo, Ligia Traldi, et al.
Publicado: (2019)

Evaluation of the quality of life of patients before treatment of squamous cell carcinoma of the head and neck by means of chemoradiotherapy
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

Contribution of MicroRNAs in Chemoresistance to Cisplatin in the Top Five Deadliest Cancer: An Updated Review
por: Loren, Pía, et al.
Publicado: (2022)

Data Normalization of Urine miRNA Profiling from Head and Neck Cancer Patients Treated with Cisplatin
por: Torso, Nadine de Godoy, et al.
Publicado: (2023)

Role of pharmacist during the COVID-19 pandemic: A scoping review
por: Visacri, Marília Berlofa, et al.
Publicado: (2021)

High 15-F(2t)-Isoprostane Levels in Patients with a Previous History of Nonmelanoma Skin Cancer: The Effects of Supplementary Antioxidant Therapy
por: Freitas, Betânia de Jesus e Silva de Almendra, et al.
Publicado: (2015)

Role of miRNAs as biomarkers of COVID-19: a scoping review of the status and future directions for research in this field
por: Visacri, Marília B, et al.
Publicado: (2021)

Dysregulated MicroRNAs as Biomarkers or Therapeutic Targets in Cisplatin-Induced Nephrotoxicity: A Systematic Review
por: de Godoy Torso, Nadine, et al.
Publicado: (2021)

Cost analysis of pharmaceutical care provided to HIV-infected patients: an ambispective controlled study
por: Carnevale, Renata Cavalcanti, et al.
Publicado: (2015)

The efficacy and safety of radiotherapy combined chemotherapy for laryngeal preservation in advanced laryngeal cancer: A protocol for systematic review and meta-analysis
por: Zhang, Lei, et al.
Publicado: (2022)

Laryngeal adenoid cystic carcinoma: Three cases reports
por: Cui, Yu, et al.
Publicado: (2019)

Role of pharmacist in the management of Hansen's Disease: A scoping review
por: de Oliveira Duarte, Elza Cristina, et al.
Publicado: (2023)

Multiple symmetric lipomatosis with secondary laryngeal obstruction: A case report
por: Cui, Yu, et al.
Publicado: (2020)

Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection
por: Molino, Caroline de Godoi Rezende Costa, et al.
Publicado: (2014)

Model establishment of prognostic-related immune genes in laryngeal squamous cell carcinoma
por: Sun, Ming, et al.
Publicado: (2021)

Prognostic values and clinical relationship of TYK2 in laryngeal squamous cell cancer
por: Fang, Lucheng, et al.
Publicado: (2021)

Adverse Drug Reactions and quality deviations monitored by spontaneous reports
por: Visacri, Marília Berlofa, et al.
Publicado: (2015)

Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Sen, Fatma, et al.
Publicado: (2016)

Continuous dose-intense temozolomide and cisplatin in recurrent glioblastoma patients
por: Wang, Yu, et al.
Publicado: (2017)

Total lesion glycolysis as a predictor of clinical T3–4a laryngeal cancer with laryngectomy or nonlaryngectomy
por: Suzuki, Hidenori, et al.
Publicado: (2021)

Clinicopathological significance of SOX4 and epithelial−mesenchymal transition markers in patients with laryngeal squamous cell carcinoma
por: Zhang, Mingjie, et al.
Publicado: (2021)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Successful management of the supraclavicular artery island flap combined with a sternohyoid muscle flap for hypopharyngeal and laryngeal reconstruction
por: Wang, Qinying, et al.
Publicado: (2019)

Upregulated TC1 and downregulated Chibby were correlated with the aberrant β-catenin expression in laryngeal squamous cell carcinoma
por: Ren, Gang, et al.
Publicado: (2023)

VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
por: Moon, Ji Young, et al.
Publicado: (2017)

Genetic variability in cisplatin metabolic pathways and outcome of locally advanced head and neck squamous cell carcinoma patients
por: Ferreira, Ana Maria Castro, et al.
Publicado: (2023)

A Preoperative Nutritional Index for Predicting Cancer-Specific and Overall Survival in Chinese Patients With Laryngeal Cancer: A Retrospective Study
por: Fu, Yan, et al.
Publicado: (2016)

Efficacy Comparison Between Total Laryngectomy and Nonsurgical Organ-Preservation Modalities in Treatment of Advanced Stage Laryngeal Cancer: A Meta-Analysis
por: Fu, Xiaoyuan, et al.
Publicado: (2016)

Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer
por: Hisakane, Kakeru, et al.
Publicado: (2017)

A case report of posterior reversible encephalopathy syndrome in a patient receiving gemcitabine and cisplatin
por: Cherniawsky, Hannah, et al.
Publicado: (2017)

The combination of cisplatin and topotecan as a second-line treatment for patients with advanced/recurrent uterine cervix cancer
por: Moon, Ji Young, et al.
Publicado: (2018)

A meta-analysis of cisplatin-based concurrent chemoradiotherapy with or without cetuximab for locoregionally advanced nasopharyngeal carcinoma
por: Wang, Bi-Cheng, et al.
Publicado: (2019)

D-dimer can be a diagnostic marker for cisplatin-related aortic thrombosis: A case report
por: Matsumoto, Yu, et al.
Publicado: (2021)

Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis
por: Chen, Long, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fbo12m5g93af4q2156e1g010uq